Everyone please remember the primary goal of a phase I trial is to evaluate the safety of the vaccine before increasing participants, the secondary goal is to see if the vaccine generates an immune response. The interim results have already said they are safe and that there is a T-cell response. They are yet to state what T-cell response was achieved but I highly doubt that they will care to even speculate on robustness of response or longevity. That type of information is far more typical from a phase II or III trial. In addition, it has already been stated that the interim results are enough to go off to start to plan the phase II trials. Data analysis takes time and can’t be rushed through so be patient and the results will come.
As always, do your own research.
- Forums
- ASX - By Stock
- buyers v sellers
Everyone please remember the primary goal of a phase I trial is...
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.80 |
Change
-0.200(1.11%) |
Mkt cap ! $341.1M |
Open | High | Low | Value | Volume |
$18.00 | $18.00 | $17.75 | $46.16K | 2.581K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 122 | $17.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.91 | 32 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 122 | 17.800 |
1 | 26 | 17.740 |
1 | 443 | 17.700 |
1 | 26 | 17.650 |
1 | 200 | 17.560 |
Price($) | Vol. | No. |
---|---|---|
17.910 | 32 | 2 |
17.930 | 51 | 2 |
17.940 | 1 | 1 |
17.950 | 270 | 2 |
18.000 | 518 | 2 |
Last trade - 13.54pm 15/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online